Free Trial
NASDAQ:CDMO

Avid Bioservices (CDMO) Stock Price, News & Analysis

Avid Bioservices logo
$12.50 +0.02 (+0.12%)
Closing price 02/5/2025
Extended Trading
$12.50 0.00 (0.00%)
As of 02/5/2025 04:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Avid Bioservices Stock (NASDAQ:CDMO)

Key Stats

Today's Range
$12.47
$12.51
50-Day Range
$12.38
$12.50
52-Week Range
$6.14
$12.51
Volume
3.07 million shs
Average Volume
1.29 million shs
Market Capitalization
$799.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.25
Consensus Rating
Hold

Company Overview

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.

Remove Ads

Avid Bioservices Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

CDMO MarketRank™: 

Avid Bioservices scored higher than 20% of companies evaluated by MarketBeat, and ranked 860th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Avid Bioservices has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Avid Bioservices has received no research coverage in the past 90 days.

  • Read more about Avid Bioservices' stock forecast and price target.
  • Earnings Growth

    Earnings for Avid Bioservices are expected to grow in the coming year, from ($0.46) to ($0.23) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avid Bioservices is -5.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avid Bioservices is -5.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Avid Bioservices has a P/B Ratio of 4.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Avid Bioservices' valuation and earnings.
  • Short Interest

    There is no current short interest data available for CDMO.
  • Dividend Yield

    Avid Bioservices does not currently pay a dividend.

  • Dividend Growth

    Avid Bioservices does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CDMO.
    • Insider Buying vs. Insider Selling

      In the past three months, Avid Bioservices insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,137,009.00 in company stock.

    • Percentage Held by Insiders

      Only 3.05% of the stock of Avid Bioservices is held by insiders.

    • Percentage Held by Institutions

      97.16% of the stock of Avid Bioservices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

    • Read more about Avid Bioservices' insider trading history.
    Receive CDMO Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Avid Bioservices and its competitors with MarketBeat's FREE daily newsletter.

    CDMO Stock News Headlines

    Avid Bioservices launches new company website design
    Musk’s real agenda in D.C.
    In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…
    Double Digit IRR Likely With Avid Bioservices
    See More Headlines

    CDMO Stock Analysis - Frequently Asked Questions

    Avid Bioservices' stock was trading at $12.35 at the beginning of the year. Since then, CDMO stock has increased by 1.2% and is now trading at $12.4950.
    View the best growth stocks for 2025 here
    .

    Avid Bioservices, Inc. (NASDAQ:CDMO) posted its earnings results on Tuesday, December, 10th. The biopharmaceutical company reported ($0.27) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by $0.14. Avid Bioservices had a negative net margin of 101.07% and a negative trailing twelve-month return on equity of 33.18%.

    Avid Bioservices's stock reverse split before market open on Monday, July 10th 2017. The 1-7 reverse split was announced on Friday, July 7th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 7th 2017. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

    Top institutional investors of Avid Bioservices include Vanguard Group Inc. (5.90%), FIL Ltd (4.00%), Royal Bank of Canada (3.92%) and Alpine Associates Management Inc. (3.04%). Insiders that own company stock include Nicholas Stewart Green, Daniel R Hart, Joseph Carleone, Richard B Hancock, Mark R Ziebell, Richard A Richieri, Matthew R Kwietniak and Gregory Sargen.
    View institutional ownership trends
    .

    Shares of CDMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Avid Bioservices investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY) and Humana (HUM).

    Company Calendar

    Last Earnings
    12/10/2024
    Today
    3/24/2025
    Next Earnings (Estimated)
    4/23/2025
    Fiscal Year End
    4/30/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:CDMO
    Employees
    320
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $12.25
    High Stock Price Target
    $12.50
    Low Stock Price Target
    $12.00
    Potential Upside/Downside
    -2.0%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    4 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    $-140,750,000.00
    Net Margins
    -101.07%
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    $139.91 million
    Cash Flow
    $0.15 per share
    Price / Cash Flow
    80.92
    Book Value
    $3.02 per share
    Price / Book
    4.14

    Miscellaneous

    Free Float
    62,012,000
    Market Cap
    $799.18 million
    Optionable
    Optionable
    Beta
    1.39

    Social Links

    7 Top Nuclear Stocks To Buy Now Cover

    Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

    Get This Free Report

    This page (NASDAQ:CDMO) was last updated on 3/24/2025 by MarketBeat.com Staff
    From Our Partners